This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Francois Nader, MD, President And CEO Of NPS Pharmaceuticals, Named EY Entrepreneur Of The Year™ 2013 National Life Sciences Award Winner

BEDMINSTER, N.J., Nov. 17, 2013 /PRNewswire/ --   Francois Nader, MD, President and CEO of NPS Pharmaceuticals, has been named the EY Entrepreneur Of The Year 2013 National Life Sciences Award winner. The EY Entrepreneur Of The Year Award is the country's most prestigious business award for entrepreneurs. The award encourages entrepreneurial activity and recognizes leaders and visionaries who demonstrate innovation, financial success and personal commitment as they create and build world-class businesses.

(Logo: http://photos.prnewswire.com/prnh/20130701/NY40565LOGO-b)

Dr. Nader was recognized for leading NPS from dire circumstances to a thriving, $1+ billion market cap life sciences company in a very short period of time. He was honored at the Entrepreneur Of The Year Awards gala, the culminating event of the EY Strategic Growth Forum® in Palm Springs, Calif. The Forum is the nation's premier gathering of high-growth, market-leading companies. Awards were given in 10 additional categories. The EY Entrepreneur Of The Year Award winners were selected by an independent panel of judges from more than 250 regional award recipients.

"We are pleased to honor Dr. Francois Nader with this esteemed award and recognize him for his entrepreneurial vision, drive and determination – all of which continue to make a positive impact on the future of health care," said Bryan Pearce, EY Americas Director, Entrepreneur Of The Year.

Navigating through "the perfect storm"Dr. Nader describes the state of NPS when he arrived in 2006 as "the perfect storm." The then-management team genuinely believed that their lead product in development would soon be approved. They were so sure they would be a revenue generating company in the very near term they took on significant debt without blinking an eye. Unfortunately, the product approval never came to fruition, and NPS did not know where to turn. There was no "Plan B," so the company found itself with a stock price that plummeted 80% and hundreds of employees that it suddenly did not need.

When Dr. Nader joined and examined the company's assets he concluded that they could be redeployed in a new direction to create value. He moved NPS to a virtual business model - retaining only core competencies in-house and outsourcing or partnering the rest, giving the company access to specific expertise, technologies, and facilities, only as needed.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,659.53 -13.07 -0.07%
S&P 500 2,053.37 +1.55 0.08%
NASDAQ 4,762.8050 +4.9260 0.10%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs